BioMarin Pharmaceutical Total Non-Operating Income/Expense 2010-2024 | BMRN

BioMarin Pharmaceutical total non-operating income/expense for the twelve months ending September 30, 2024 was $0.069B, a 290.44% increase year-over-year.

  • BioMarin Pharmaceutical annual total non-operating income/expense for 2023 was $0.03B, a 217514.29% increase from 2022.
  • BioMarin Pharmaceutical annual total non-operating income/expense for 2022 was $0B, a 99.8% decline from 2021.
  • BioMarin Pharmaceutical annual total non-operating income/expense for 2021 was $0.007B, a 225.81% decline from 2020.

BioMarin Pharmaceutical Total Non-Operating Income/Expense 2010-2024 | BMRN

  • BioMarin Pharmaceutical annual total non-operating income/expense for 2023 was $0.03B, a 217514.29% increase from 2022.
  • BioMarin Pharmaceutical annual total non-operating income/expense for 2022 was $0B, a 99.8% decline from 2021.
  • BioMarin Pharmaceutical annual total non-operating income/expense for 2021 was $0.007B, a 225.81% decline from 2020.